179 related articles for article (PubMed ID: 11843553)
1. Melanoma metastatic to the breast: utility of fine needle aspiration and immunohistochemistry.
Filie AC; Simsir A; Fetsch P; Abati A
Acta Cytol; 2002; 46(1):13-8. PubMed ID: 11843553
[TBL] [Abstract][Full Text] [Related]
2. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody.
Beaty MW; Fetsch P; Wilder AM; Marincola F; Abati A
Cancer; 1997 Feb; 81(1):57-63. PubMed ID: 9100543
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
4. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.
Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA
BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
6. Fine-needle aspiration of metastatic melanoma presenting as bilateral breast cysts.
Inouye CM; Cimino-Mathews A; Eisner D; Rosenthal DL; VandenBussche CJ
Diagn Cytopathol; 2017 May; 45(5):446-451. PubMed ID: 28322032
[TBL] [Abstract][Full Text] [Related]
7. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
[TBL] [Abstract][Full Text] [Related]
10. Metastatic melanoma presenting as an isolated breast tumor: a study of 20 cases with emphasis on several primary mimickers.
Bacchi CE; Wludarski SC; Ambaye AB; Lamovec J; Salviato T; Falconieri G
Arch Pathol Lab Med; 2013 Jan; 137(1):41-9. PubMed ID: 23276173
[TBL] [Abstract][Full Text] [Related]
11. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
[TBL] [Abstract][Full Text] [Related]
12. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
13. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
14. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
15. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
Jäger E; Ringhoffer M; Altmannsberger M; Arand M; Karbach J; Jäger D; Oesch F; Knuth A
Int J Cancer; 1997 Apr; 71(2):142-7. PubMed ID: 9139833
[TBL] [Abstract][Full Text] [Related]
16. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma metastatic to the liver. A cytomorphologic comparative study to identify reproducible diagnostic criteria.
De Las Casas LE; Gokden M; Baker SJ; Korourian S; Hermonat PL; You H; Miranda RN; Shalkham JE; O'Brien LA; Mukunyadzi P
Acta Cytol; 2004; 48(1):32-8. PubMed ID: 14969178
[TBL] [Abstract][Full Text] [Related]
18. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.
Marincola FM; Hijazi YM; Fetsch P; Salgaller ML; Rivoltini L; Cormier J; Simonis TB; Duray PH; Herlyn M; Kawakami Y; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):192-205. PubMed ID: 8811494
[TBL] [Abstract][Full Text] [Related]
19. Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.
Erdag G; Chowdhuri SR; Fetsch P; Erickson D; Hughes MS; Filie AC
Diagn Cytopathol; 2013 Oct; 41(10):847-51. PubMed ID: 23554410
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases.
Gupta D; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2004 Jun; 28(6):771-80. PubMed ID: 15166669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
